Skip to main content
Top

International Journal of Clinical Oncology

Issue 2/2002

Content (10 Articles)

REVIEW ARTICLE

Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors

Y. Ku, M. Tominaga, T. Iwasaki, T. Fukumoto, Y. Kuroda

ORIGINAL ARTICLE

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese

N. Hamajima, K. Matsuo, H. Iwata, M. Shinoda, Y. Yamamura, T. Kato, S. Hatooka, T. Mitsudomi, M. Suyama, Y. Kagami, M. Ogura, M. Ando, Y. Sugimura, K. Tajima

REVIEW ARTICLE

Current and future trends in management and treatment of Klatskin tumour

B. Launois, S. Wemyss-Holden, G. J. Maddern

ORIGINAL ARTICLE

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer

Y. H. Kim, J. S. Kim, Y. H. Choi, K. H. In, H. S. Park, D. S. Hong, T. J. Jeong, Y. Y. Lee, E. Nam, S. N. Lee, K. S. Lee, H. K. Kim

CASE REPORT

Renal angiomyolipoma with minimal fat

Y. Hosokawa, T. Kinouchi, Y. Sawai, M. Mano, H. Kiuchi, N. Meguro, O. Maeda, M. Kuroda, M. Usami

CASE REPORT

Severe gustatory disorder caused by cisplatin and etoposide

Y. Minakata, T. Yamagata, H. Nakanishi, T. Nishimoto, M. Nakanishi, M. Mune, S. Yukawa

CASE REPORT

A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis

H. Tanemura, H. Ohshita, A. Kanno, M. Kusakabe, E. Tomita, Y. Nishigaki, A. Sugiyama, T. Yamada

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine